Zilucoplan is the first once-daily, subcutaneous, self-administered, targeted C5 complement inhibitor for adults with gMG who are AChR antibody positive.
In patients with heart failure, mid-upper arm circumference and arm muscle circumference are more associated with prognosis than skeletal muscle mass index or calf circumference, data suggest.
Baby Ben Kutschke was diagnosed at 3 months with spinal muscular atrophy, a rare inherited disorder which is the leading genetic cause of death in infancy globally.